Cyprus/Greece/MaltaCyprusGreeceMalta

New biotech laws for Malta

12.08.2005

La Valetta - After a broad discussion process Malta's Social Affairs Committee has presented a draft regulation on biotechnology and assisted reproduction to the parliament in July.
According to the proposals the fertilised ovum will be given the status of an embryo with full human rights. Consequently, creation of embryos for research purposes and cloning will be prohibited. But cells extracted from the umbilical cord blood, placenta, as well as adult stem cells could be used for research, while cells from a natural miscarriage are accessible only with the permission of the parents.
Genetic diagnosis should be allowed on condition that it is used for medical and forensic reasons only, or to correct specific abnormalities in the embryo. Pre-implantation diagnosis will be prohibited, pre-natal testing should be allowed if there is a possibility of the parents passing on a genetic disease to their children.
Assisted procreation should be allowed under certain conditions: third party donors and surrogate motherhood should not be allowed. In cases where the parents are not able to use the embryos - due to the mother's death, for example - these embryos can be put up for adoption according to Maltese law.
Nationalist MP Clyde Puli - Chairman of the Committee - pointed out that after seven months of discussion, the time has come to take a decision. Concerning the protest of members of opposition he added that once the law was implemented, changes could be made through a legal notice.
However, the Committee's recomendations have been met with mixed reactions in professional circles. While many medical professionals agree that it is important to include a clear legal definition of the beginning of human life, most doctors seem to see the definition put forward by the Committee as, at best, “a conservative compromise.” Especially gynaecologists have expressed their concern that the Committee's definition might “hinder the process of IVF”.

Cyprus/Greece/MaltaCyprusGreeceMalta

05.02.2004

Athens/Heraklion - Last year the National Centre for Marine Research (NCMR), Anavissos, and the Institute of Marine Biology of Crete (IMBC), Hera-klion, were merged to create a new organisation for marine research, which is now...

Cyprus/Greece/MaltaCyprusGreeceMalta

05.02.2004

Limassol - At the end of last year the “1st Course in Genetic and Acquired Thrombophilia: Investigation and Management” took place with strong participation from European scientists and managers. The event was sponsored by the...

Cyprus/Greece/MaltaCyprusGreeceMalta

05.02.2004

Attard - Synergene Profiling Ltd., a subsidiary of Malta-based Synergene Technologies, specialized in DNA profiling services, recently completed a financing agreement with the Institute for Promotion of Small Enterprise (IPSE),...

Cyprus/Greece/MaltaCyprusGreeceMalta

23.11.2003

Valetta/Strasbourg - The European Parliament's (EP) vote in favour of allowing member states to take action to prevent “contamination” from genetically modified (GM) crops has been warmly welcomed by Friends of the Earth (FoE) in...

Cyprus/Greece/MaltaCyprusGreeceMalta

16.09.2003

Thessaloniki/Como - Research within textile biotechnology is very broad and involves areas such as enzymology, chemistry, fibre testing, textile technology and effluent treatment process technology. COST Action 847...

Cyprus/Greece/MaltaCyprusGreeceMalta

16.09.2003

Attard/Antwerp - DNA tests are moving in a big way out of the research laboratory and into the realm of diagnostic medicine.Fifty years after Watson and Crick published the structure of DNA in Nature, an extensive diagnostic...

Cyprus/Greece/MaltaCyprusGreeceMalta

16.09.2003

Attard - Synergene Holdings Ltd. has been recently joined by Dr. Marios Kambouris, a world-leading geneticist with particular specialization in mapping genes that cause human inherited diseases. Dr. Kambouris has been employed as...

Displaying results 41 to 47 out of 47

< Previous 41-47

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-cyprus-greece-malta/browse/4/article/new-biotech-laws-for-malta.html

Print Magazine

Event Video

All videos

Events

All Events

Stock list

All quotes

TOP

  • 4SC0.97 EUR15.48%
  • THERAMETRICS0.08 CHF14.29%
  • CYTOS0.17 CHF13.33%

FLOP

  • MOLOGEN6.60 EUR-13.16%
  • WILEX2.15 EUR-1.83%
  • ADDEX3.40 CHF-1.16%

TOP

  • BIOFRONTERA2.92 EUR32.7%
  • BB BIOTECH157.00 EUR7.2%
  • ADDEX3.40 CHF6.6%

FLOP

  • PAION2.22 EUR-31.9%
  • CYTOS0.17 CHF-19.0%
  • MAGFORCE5.95 EUR-15.6%

TOP

  • SANTHERA84.30 CHF2248.2%
  • CO.DON2.84 EUR202.1%
  • PAION2.22 EUR161.2%

FLOP

  • CYTOS0.17 CHF-95.7%
  • 4SC0.97 EUR-44.3%
  • THERAMETRICS0.08 CHF-42.9%

No liability assumed, Date: 22.10.2014


Current issue

All issues

Product of the week

Products